Southern District Court of New York Rules Patent for ACIPHEX Enforceable
Health is a unity and harmony within the mind, body and spirit which is unique to each person, and is as defined by that person. The level of wellness or health is, in part, determined by the ability to deal with and defend against stress. Health is determined by physiological, psychological, socio-cultural, spiritual, and developmental stage variables.
Southern District Court of New York Rules Patent for ACIPHEX Enforceable

GERD :: Southern District Court of New York Rules Patent for ACIPHEX Enforceable
PriCara?, Unit of Ortho-McNeil, Inc., announced that the Southern District Court of New York ruled that the patent for ACIPHEX? (rabeprazole sodium 20 mg tablets) is enforceable. PriCara and Eisai Inc. co-promote ACIPHEX in the United States.
In an earlier ruling, the Court confirmed the validity of the ACIPHEX composition of matter patent. Today?s decision and the earlier court ruling ensure that the patent is protected and that FDA approved generic versions of rabeprazole sodium will be available no earlier than the date of the patent expiration, May 2013, unless overturned on appeal.
?We are pleased by the Court?s decision, which reflects our belief that the patent for ACIPHEX, previously found to be valid, is enforceable,? said Jeffrey N. Smith, president, Ortho-McNeil, Inc.
Eisai Co. Ltd. of Tokyo, Japan, holds the patent for ACIPHEX, and Eisai Inc. of Woodcliff, Lake, N.J., is the exclusive licensee.
ACIPHEX is used for the treatment of persistent heartburn and other symptoms associated with acid reflux disease. It also is used for the short-term treatment in the healing and symptom relief of erosive acid reflux disease ? gastroesophageal reflux disease ? and to maintain healing of erosion and relief of heartburn symptoms that happen with acid reflux disease.
ACIPHEX has a well established safety profile. The most common side effect possibly related to ACIPHEX is headache. Symptom relief does not rule out other serious stomach conditions. Patients on warfarin (such as Coumadin?) may need to be monitored closely by their doctor. For more information, visit www.aciphex.com.
(
GERD :: Southern District Court of New York Rules Patent for ACIPHEX Enforceable published at
SpiritIndia on Monday, May 14, 2007)
Search more information on
GERDRecently posted related articles on GERD :
- GERD :: New studies reveal that night-time acid reflux can impact sleep
- Heartburn :: Tips on Heartburn Relief for GERD patients
- GERD :: Doctors, engineers develop new wireless system to detect esophageal reflux
- GERD :: Southern District Court of New York Rules Patent for ACIPHEX Enforceable
- GERD :: Teva Provides Update on Generic Aciphex Litigation
- GERD :: New reflux guidelines released
- GERD :: Study demonstrates long-term durability of Plicator procedure in GERD
- GERD :: Acidity medication increases hip fracture risks
- GERD :: Obesity linked to acid reflux disease
- GERD :: Fatty foods, alcohol and overeating are triggers for acid reflux
»»
Stroke :: Minor strokes hardly harmless««
Gastric Ulcer :: Axcan announces the U.S. Launch of PYLERA, Therapy for the Eradication of Helicobacter PyloriThe information provided on
SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information.
Health,
Business,
Science,
Sports,
Entertainment,
Technology
©2002-2009 SpiritIndia.com